| Code | CSB-RA33255A0GMY |
| Size | US$320 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
| Application | Recommended Dilution |
|---|---|
| ELISA | 1:10000-1:50000 |
| GICA | 1:500-1:2000 |
The SARS-CoV-2 nucleocapsid protein serves as one of the most abundant viral proteins during infection, playing essential roles in viral RNA packaging, replication, and host cell interactions. Its high immunogenicity and conservation make it a primary target for diagnostic development and fundamental coronavirus research, complementing spike protein-focused studies with insights into viral assembly and pathogenesis.
This recombinant monoclonal antibody targeting the SARS-CoV-2 nucleocapsid protein offers the reproducibility and consistency that diagnostic and research applications demand. As a chimeric construct combining mouse variable regions with human kappa and IgG1 constant domains, it provides sequence-defined performance that eliminates the lot-to-lot variability inherent in traditional hybridoma production. The antibody was raised against a recombinant nucleoprotein construct spanning amino acids 1-419, ensuring recognition of properly folded epitopes.
Validation data demonstrate exceptional performance characteristics across immunoassay platforms. In functional ELISA, the antibody achieves an EC50 of 6.892 ng/ml, indicating high-affinity binding suitable for sensitive detection work. The recommended ELISA dilution range of 1:10000 to 1:50000 reflects this potency. For rapid testing applications, colloidal gold immunochromatography assay validation shows clean background signal with detection limits reaching 446.4 ng/ml, supporting point-of-care diagnostic development. Critically, specificity testing confirms no cross-reactivity with nucleocapsid proteins from related human coronaviruses including NL63-CoV, HCoV-OC43, HCoV-229E, and HCoV-HKU1, ensuring reliable discrimination of SARS-CoV-2 in samples where multiple coronavirus exposures may be relevant.
This antibody supports researchers developing SARS-CoV-2 diagnostic platforms, studying viral protein biology, or requiring a reliable detection reagent for nucleocapsid-focused coronavirus investigations.
There are currently no reviews for this product.